SUPN · Supernus Pharmaceuticals, Inc. · Documents
$41.16
-0.08 (-0.18%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.40B
Shares
58.13M
Volume · Oct 21
767.79K
Avg daily vol (3M)
808.16K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-05-07 | 2020-05-05 | |
| 8-K | — | 2020-05-04 | 2020-04-28 | |
| DEFA14A | — | 2020-05-04 | — | |
| 8-K | — | 2020-04-27 | 2020-04-21 | |
| 8-K | — | 2020-04-27 | 2020-04-24 | |
| DEF 14A | — | 2020-04-24 | 2020-06-15 | |
| DEFA14A | — | 2020-04-24 | — | |
| 8-K | — | 2020-04-03 | 2020-03-30 | |
| 10-K | — | 2020-02-28 | 2019-12-31 | |
| 8-K | — | 2020-02-27 | 2020-02-21 | |
| 8-K | — | 2020-02-11 | — | |
| 8-K | — | 2020-01-23 | 2020-01-21 | |
| 8-K | — | 2020-01-08 | — |
Showing 201–213 of 213 filings
Key facts
CIK
1356576
CUSIP
868459108
13F (30d)
37 filings
36 filers
Visit website
Investor relations